Literature DB >> 31374036

Deep vein thrombosis secondary to abdominal aortic aneurysm: A case report.

Zhong Ning Leonard Goh1,2,3, Joanna Chen-Yeen Seak2, Chen-Ken Seak2, Chen-Te Wu4, Chen-June Seak3,5.   

Abstract

RATIONALE: Abdominal aortic aneurysm is an extremely rare cause of deep vein thrombosis. Here we report an elderly gentleman who presented with deep vein thrombosis and was found to have concomitant abdominal aortic aneurysm upon ultrasonographic screening. It illustrates the possibility of such an aetiology, and the importance of screening for such aneurysms in a select patient population before heparinization. PATIENT CONCERNS: A 73-year-old Asian gentleman with underlying hypertension, hyperlipidaemia, chronic renal failure, and history of chronic smoking presented to the emergency department with acute left lower limb swelling of 1 day. On examination, the patient was tachycardic (110 beats/minute) and hypertensive (168/84 millimeters mercury (mmHg)). The entire left lower limb was swollen with notable pitting oedema, tenderness, and warmth; left calf swelling was measured to be 4 centimeters (cm). DIAGNOSES: The patient's Wells score of 4 placed him in the high-risk group for deep vein thrombosis. Serum D-dimer was subsequently found to be elevated at 926 nanograms/milliliter (ng/ml). Compression ultrasonography revealed a thrombus in the left deep femoral vein, confirming the diagnosis of deep vein thrombosis. The ultrasonographic evaluation was extended to the abdominal aorta due to the patient's high risk of abdominal aortic aneurysm, and a 7-cm aneurysm was indeed found. Further computed tomography and magnetic resonance imaging localized it to the infrarenal region, with left common iliac vein compression resulting in stagnant venous return.
INTERVENTIONS: Emergency endovascular repair was performed with insertion of an inferior vena cava filter. OUTCOMES: The patient was subsequently monitored in the intensive care unit and uneventfully discharged after 2 weeks. LESSONS: Such clinical presentations of deep vein thrombosis are rare, but physicians are reminded to consider screening for abdominal aneurysms and other anatomical causes before heparinization in patients who seemingly do not have thromboembolic risk factors. This is especially so for the high risk group of male deep vein thrombosis patients aged 65-75 years with a history of smoking who have yet to be screened for abdominal aortic aneurysms, in line with United States Preventive Services Task Force recommendations.

Entities:  

Mesh:

Year:  2019        PMID: 31374036      PMCID: PMC6708920          DOI: 10.1097/MD.0000000000016645

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


Introduction

Deep vein thrombosis refers to thrombosis occurring in the deep venous system. Its causes can be generally classified as either hereditary or acquired, though all share a common pathogenesis pathway of Virchow triad: alterations in blood flow, vascular endothelial injury, and alterations in the constituents of blood.[ The common acquired causes include immobilization, cancer, and recent surgical procedures or trauma. Abdominal aortic aneurysms refer to segmental full-thickness dilatations of the abdominal aorta that has an aortic diameter of ≥3.0 cm.[ Its estimated prevalence is approximately 4% to 8% in men older than 50 years and 1% to 1.3% in women.[ Abdominal aortic aneurysms can be either asymptomatic and picked up through screening or an incidental finding, or symptomatic. Symptoms commonly include abdominal, back, or flank pain, limb ischemia, and aneurysmal rupture. Here, we present a patient who presented to the emergency department with deep vein thrombosis secondary to an abdominal aortic aneurysm. This report illustrates the possibility of such a clinical presentation of abdominal aortic aneurysms, and the importance of screening in elderly men who have ever smoked as recommended by the United States Preventive Services Task Force before heparinization. This case report was approved by the Institutional Review Board of Chang Gung Medical Foundation (#201800876B0). Informed written consent was obtained from the patient for publication of this case report and accompanying images.

Case report

A 73-year-old Asian gentleman with underlying hypertension, hyperlipidaemia, chronic renal failure, and history of chronic smoking presented to the emergency department with acute left lower limb swelling of 1 day. On examination, the patient was tachycardic (110 beats/minute) and hypertensive (168/84 mm Hg). The entire left lower limb was swollen with notable pitting oedema, tenderness, and warmth (Fig. 1A); left calf swelling was measured to be 4 cm. The patient's Wells score of 4 thus placed him in the high-risk group for deep vein thrombosis. Serum D-dimer was subsequently found to be elevated at 926 ng/ml.
Figure 1

(A) The patient's left lower limb was swollen from calf up to upper thigh, with notable pitting edema. (B) Axial T2 weighted image of magnetic resonance scan revealed an infrarenal abdominal aortic aneurysm (AAo) with marked luminal dilatation and ulcerative plaques that displaced the right common iliac vein (single arrow) and compressed the left common iliac vein (double arrow).

(A) The patient's left lower limb was swollen from calf up to upper thigh, with notable pitting edema. (B) Axial T2 weighted image of magnetic resonance scan revealed an infrarenal abdominal aortic aneurysm (AAo) with marked luminal dilatation and ulcerative plaques that displaced the right common iliac vein (single arrow) and compressed the left common iliac vein (double arrow). Compression ultrasonography revealed a thrombus in the left deep femoral vein, confirming the diagnosis of deep vein thrombosis. The ultrasonographic evaluation was extended to the abdominal aorta before heparinization due to the patient's high risk of abdominal aortic aneurysm, and a 7-cm aneurysm was indeed found. Further computed tomography and magnetic resonance imaging localized it to the infrarenal region, with left common iliac vein compression resulting in stagnant venous return (Fig. 1B). Emergency endovascular repair was performed with insertion of an inferior vena cava filter. The patient was subsequently monitored in the intensive care unit and uneventfully discharged after 2 weeks.

Discussion

The prevalence of abdominal aortic aneurysms for men aged above 50 years is not insignificant at 3.9% to 7.2%. These aneurysms typically are clinically silent till their spontaneous rupture leading to death in 75% to 90% of cases. Despite such catastrophic consequences of the failure to detect and treat abdominal aortic aneurysms early, effectiveness studies by the United States Preventive Services Task Force revealed that non-selective screenings were appropriate only for the patient population of men aged 65 to 75 years who have ever smoked. It therefore recommends one-time screening for aortic aneurysms in this population.[ The pathogenesis of aortic aneurysms has yet to be fully elucidated, though it is generally accepted to be a multifactorial, systemic process originating from alterations in vascular wall biology and strength. Several risk factors associated with abdominal aortic aneurysms have nevertheless been identified,[ of which our patient has the following: older age, male gender, cigarette smoker, and underlying hypertension. The development of the identified aneurysm in the infrarenal segment of the abdominal aorta in our patient then led to compression of his left common iliac vein with stagnant venous return as shown in Figure 1B, constituting the “stasis” factor of Virchow triad. Blood stasis was further compounded by hypercoagulability secondary to chronic renal failure in our patient, which is associated with a relative thromboembolic risk of 1.7 as compared to patients with normal renal function.[ This increased risk is hypothesized to be due to elevated levels of Factor VIII and von Willebrand factor in chronic renal disease patients.[ These factors ultimately resulted in extensive deep vein thrombosis in our patient manifesting as acute swelling of his left lower limb. Physicians should keep in mind that deep vein thrombosis can be caused by abdominal aortic aneurysms.[ This is especially so if the patient seemingly does not have other risk factors typically associated with deep vein thrombosis. Our case report further illustrates the merits of the United States Preventive Services Task Force's recommendation of performing a one-off screening for aortic aneurysms in elderly male patients who have ever smoked. The recognition and diagnosis of this patient's abdominal aortic aneurysm prior to treatment of his deep vein thrombosis was crucial to his management. Based on treatment protocols, deep vein thrombosis is a medical emergency that requires immediate heparinization to minimize the risk of a life-threatening embolization.[ Yet, anticoagulants are generally contraindicated in surgical procedures. Administration of anticoagulants prior to discovery of the aneurysm would have greatly complicated our patient's management, in that the emergency endovascular surgical repair of the aneurysm would have had to be delayed till his coagulation profile returns to normal. His mortality risk would have been further compounded by the high risk of aneurysmal rupture, estimated at 20% to 40% annually for his aneurysm of diameter 7 cm.[ Our adherence to the United States Preventive Services Task Force's recommendation in this patient with high risk of abdominal aortic aneurysm therefore helped to identify the aneurysm prior to initiation of anticoagulant therapy, averting the tragedy of an inoperable abdominal aortic aneurysm rupture and subsequent near-certain death.

Conclusion

We report a case of deep vein thrombosis caused by an abdominal aortic aneurysm. Such clinical presentations of deep vein thrombosis are rare, but physicians are reminded to consider screening for abdominal aneurysms and other anatomical causes before heparinization in patients who seemingly do not have thromboembolic risk factors. This is especially so for the high risk group of male deep vein thrombosis patients aged 65 to 75 years with a history of smoking who have yet to be screened for abdominal aortic aneurysms, in line with United States Preventive Services Task Force recommendations.

Author contributions

Conceptualization: Zhong Ning Leonard Goh, Joanna Chen-Yeen Seak, Chen-Ken Seak, Chen-Te Wu, Chen-June Seak. Resources: Chen-Te Wu, Chen-June Seak. Supervision: Chen-June Seak. Writing – original draft: Joanna Chen-Yeen Seak, Chen-Ken Seak, Chen-June Seak. Writing – review & editing: Zhong Ning Leonard Goh, Chen-June Seak. Chen-June Seak orcid: 0000-0003-0984-8385.
  10 in total

1.  Virchow and his triad: a question of attribution.

Authors:  Catherine N Bagot; Roopen Arya
Journal:  Br J Haematol       Date:  2008-09-06       Impact factor: 6.998

2.  Screening for abdominal aortic aneurysm: U.S. Preventive Services Task Force recommendation statement.

Authors:  Michael L LeFevre
Journal:  Ann Intern Med       Date:  2014-08-19       Impact factor: 25.391

3.  Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals.

Authors:  K Craig Kent; Robert M Zwolak; Natalia N Egorova; Thomas S Riles; Andrew Manganaro; Alan J Moskowitz; Annetine C Gelijns; Giampaolo Greco
Journal:  J Vasc Surg       Date:  2010-07-13       Impact factor: 4.268

4.  Role of hemostatic factors on the risk of venous thrombosis in people with impaired kidney function.

Authors:  Gürbey Ocak; Carla Y Vossen; Willem M Lijfering; Marion Verduijn; Friedo W Dekker; Frits R Rosendaal; Suzanne C Cannegieter
Journal:  Circulation       Date:  2013-11-08       Impact factor: 29.690

5.  Early anticoagulation is associated with reduced mortality for acute pulmonary embolism.

Authors:  Sean B Smith; Jeffrey B Geske; Jennifer M Maguire; Nicholas A Zane; Rickey E Carter; Timothy I Morgenthaler
Journal:  Chest       Date:  2010-01-15       Impact factor: 9.410

6.  Impact of delay in clinical presentation on the diagnostic management and prognosis of patients with suspected pulmonary embolism.

Authors:  Paul L den Exter; Josien van Es; Petra M G Erkens; Mark J G van Roosmalen; Pim van den Hoven; Marcel M C Hovens; Pieter W Kamphuisen; Frederikus A Klok; Menno V Huisman
Journal:  Am J Respir Crit Care Med       Date:  2013-06-15       Impact factor: 21.405

7.  Chronic kidney disease increases risk for venous thromboembolism.

Authors:  Keattiyoat Wattanakit; Mary Cushman; Catherine Stehman-Breen; Susan R Heckbert; Aaron R Folsom
Journal:  J Am Soc Nephrol       Date:  2007-11-21       Impact factor: 10.121

Review 8.  Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery.

Authors:  David C Brewster; Jack L Cronenwett; John W Hallett; K Wayne Johnston; William C Krupski; Jon S Matsumura
Journal:  J Vasc Surg       Date:  2003-05       Impact factor: 4.268

9.  Abdominal aortic aneurysm with inferior vena cava compression in association with deep venous thrombosis.

Authors:  Ryan D Moore; Elizabeth D Rutter; Daniel R Zapko; Victor O Kolade; Shadi M Ayyoub
Journal:  Am J Med Sci       Date:  2013-12       Impact factor: 2.378

10.  Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery.

Authors:  K W Johnston; R B Rutherford; M D Tilson; D M Shah; L Hollier; J C Stanley
Journal:  J Vasc Surg       Date:  1991-03       Impact factor: 4.268

  10 in total
  1 in total

1.  [Deep vein thrombosis as a primary symptom of abdominal aortic aneurysm : Bilateral deep vein thrombosis caused by infrarenal abdominal aortic aneurysm (15 cm in diameter) with complete compression of the inferior vena cava].

Authors:  D Körfer; C Uhl; K Meisenbacher; M Dufner; N Frey; D Böckler; M S Bischoff
Journal:  Inn Med (Heidelb)       Date:  2022-02-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.